Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China flag China · Delayed Price · Currency is CNY
31.70
-0.43 (-1.34%)
May 19, 2026, 4:00 PM EDT

SHE:301246 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
12,5799,9205,38510,392--
Market Cap Growth
147.30%84.22%-48.18%---
Enterprise Value
11,5879,2034,0688,758--
Last Close Price
31.7025.0013.5025.83--
PE Ratio
49.4583.33104.64119.22--
PS Ratio
5.695.123.045.06--
PB Ratio
2.732.231.242.38--
P/TBV Ratio
2.842.321.292.49--
P/OCF Ratio
---294.81--
EV/Sales Ratio
5.244.752.304.26--
EV/EBITDA Ratio
21.4524.2219.1039.79--
EV/EBIT Ratio
35.3651.58115.30136.98--
Debt / Equity Ratio
0.130.120.090.080.210.05
Debt / EBITDA Ratio
1.111.381.751.581.240.18
Net Debt / Equity Ratio
-0.21-0.24-0.38-0.42-0.02-0.02
Net Debt / EBITDA Ratio
-1.85-2.81-7.75-8.32-0.15-0.09
Net Debt / FCF Ratio
3.533.149.384.170.180.66
Asset Turnover
0.360.320.310.430.650.75
Inventory Turnover
5.385.346.886.674.402.89
Quick Ratio
2.272.062.353.200.931.01
Current Ratio
2.882.662.683.501.261.67
Return on Equity (ROE)
5.64%2.67%1.18%2.69%22.93%34.51%
Return on Assets (ROA)
3.37%1.86%0.38%0.84%5.18%10.62%
Return on Invested Capital (ROIC)
7.92%4.72%1.16%2.46%12.86%23.80%
Return on Capital Employed (ROCE)
6.40%3.60%0.80%1.40%10.20%19.60%
Earnings Yield
2.02%1.20%0.96%0.84%--
FCF Yield
-2.23%-3.44%-3.27%-4.23%--
Dividend Yield
0.09%-0.22%0.19%--
Payout Ratio
11.36%23.58%59.97%61.72%3.44%0.45%
Buyback Yield / Dilution
0.21%0.42%-2.71%-10.02%0.00%-0.13%
Total Shareholder Return
0.30%0.42%-2.49%-9.83%0.00%-0.13%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.